Literature DB >> 18031996

Mortality in schizophrenia and schizoaffective disorder: an Olmsted County, Minnesota cohort: 1950-2005.

Rebecca M Capasso1, Timothy W Lineberry, J Michael Bostwick, Paul A Decker, Jennifer St Sauver.   

Abstract

INTRODUCTION: Increased mortality in people with schizophrenia, compared to the general population, has been consistently reported worldwide. This mortality has been attributed predominantly to "unnatural" deaths-suicide, accidents, and homicide. Recent studies have shown an increase in natural causes of death. Our objective is to compare the mortality of schizophrenic and schizoaffective subjects to the general US population.
METHODS: 319 Olmsted County residents meeting DSM-IV-TR criteria for schizophrenia or schizoaffective disorder seen at the Mayo Clinic between 1950 and 1980 were followed until February 2005 for a median of 23.5 years.
RESULTS: At the end of follow-up, 44% of patients were deceased. Mortality was significantly (p<0.001) increased compared to the Caucasian population in the US for persons of like age, gender, and calendar year of birth. The median survival following diagnosis was 36.2 years. Death certificate cited cause of death was cardiac (29%), cancer--including lung (19%), and pulmonary disease (17%). Concerningly, there was no association with the year of diagnosis to survival.
CONCLUSIONS: Tsuang and colleagues showed in 1975 that mortality in schizophrenics and later, those with schizoaffective disorder was significantly increased compared to the US general population. Thirty years later, with a demographically similar population, we have found the same pattern of increased mortality. In light of continued improvements in the general population's lifespan, the survival gap in schizophrenia/schizoaffective disorder appears to be increasing.

Entities:  

Mesh:

Year:  2007        PMID: 18031996     DOI: 10.1016/j.schres.2007.10.005

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  48 in total

1.  Genetic variations in the ADAMTS12 gene are associated with schizophrenia in Puerto Rican patients of Spanish descent.

Authors:  Irina N Bespalova; Gary W Angelo; Ben P Ritter; Jason Hunter; Maria L Reyes-Rabanillo; Larry J Siever; Jeremy M Silverman
Journal:  Neuromolecular Med       Date:  2012-02-10       Impact factor: 3.843

2.  Predicting the severity of everyday functional disability in people with schizophrenia: cognitive deficits, functional capacity, symptoms, and health status.

Authors:  Philip D Harvey; Martin Strassnig
Journal:  World Psychiatry       Date:  2012-06       Impact factor: 49.548

3.  Cardiovascular risk in a first-episode psychosis sample: a 'critical period' for prevention?

Authors:  Vivek H Phutane; Cenk Tek; Lydia Chwastiak; Joseph C Ratliff; Banu Ozyuksel; Scott W Woods; Vinod H Srihari
Journal:  Schizophr Res       Date:  2011-01-15       Impact factor: 4.939

4.  The effect of dietary and physical activity pattern on metabolic profile in individuals with schizophrenia: a cross-sectional study.

Authors:  Joseph C Ratliff; Laura B Palmese; Erin L Reutenauer; Ellen Liskov; Carlos M Grilo; Cenk Tek
Journal:  Compr Psychiatry       Date:  2012-03-16       Impact factor: 3.735

Review 5.  A tail with a thorn in it: second-generation antipsychotics hand in hand with statins.

Authors:  Ronen Durst; Eran Leitersdorf
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

6.  Do smoking cessation websites meet the needs of smokers with severe mental illnesses?

Authors:  Mary F Brunette; Joelle C Ferron; Timothy Devitt; Pamela Geiger; Wendy M Martin; Sarah Pratt; Meghan Santos; Gregory J McHugo
Journal:  Health Educ Res       Date:  2011-10-10

7.  A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls.

Authors:  Davy Vancampfort; Martien Wampers; Alex J Mitchell; Christoph U Correll; Amber De Herdt; Michel Probst; Marc De Hert
Journal:  World Psychiatry       Date:  2013-10       Impact factor: 49.548

8.  Health Care and Mortality among Persons with Severe Mental Illness.

Authors:  Gilad Gal; Hanan Munitz; Itzhak Levav
Journal:  Can J Psychiatry       Date:  2016-09-24       Impact factor: 4.356

9.  Metabolic syndrome in people with schizophrenia: a review.

Authors:  Marc DE Hert; Vincent Schreurs; Davy Vancampfort; Ruud VAN Winkel
Journal:  World Psychiatry       Date:  2009-02       Impact factor: 49.548

10.  Has 'lifetime prevalence' reached the end of its life? An examination of the concept.

Authors:  David L Streiner; Scott B Patten; James C Anthony; John Cairney
Journal:  Int J Methods Psychiatr Res       Date:  2009-12       Impact factor: 4.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.